WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers…
Washington, D.C.— AdvaMedDx® has submitted comments on draft legislation, the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, commending Congress for their support of comprehensive, risk-based diagnostics regulatory reform. “An overarching,…